Eratrectinib

安瑞替尼

Report date: 2026/02/27 20:01:47
NME

Base Information

Drug NameEratrectinib
Drug Alias NameVC-004VC 004VC004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTropomyosin-related kinase inhibitors
TargetsTropomyosin-related kinase
Therapy Area/IndicationsSolid tumoursCancer PainPruritus +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursCancer PainPruritus +[4
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A